You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/13643
Title: 
CYR61, a cellular proliferation marker in dogs with prostatic disease
Author(s): 
Institution: 
  • Universidade Federal de Goiás (UFG)
  • Universidade Estadual Paulista (UNESP)
ISSN: 
0093-691X
Abstract: 
The life expectancy of dogs is increasing and is associated with a greater frequency of age-related disease, including that of the prostate gland. A marker of cell proliferation, CYR61, may be detected in a number of conditions in humans, including hyperplasia and neoplasia. The objective of the present study was to investigate the degree of CYR61 expression in a number of different prostate diseases in dogs in order to understand the potential of this marker for diagnosis of prostatic disease. Immunohistochemistry with a CYR61 antibody was performed on prostatic tissue from 22 dogs with different diseases. Intense stromal staining was observed in cases of prostatic dysplasia and benign prostate hyperplasia. In contrast, CYR61 staining was very intense in alveolar epithelial cells in cases of epithelial benign prostate hyperplasia and one case of adenocarcinoma. An obvious CYR61 staining pattern was absent in cases of prostatitis. In conclusion, CYR61 may be a useful marker of cell proliferation in a number of prostatic pathologies, although further studies of normal tissue are warranted. (c) 2006 Elsevier B.V. All rights reserved.
Issue Date: 
1-Oct-2006
Citation: 
Theriogenology. New York: Elsevier B.V., v. 66, n. 6-7, p. 1618-1620, 2006.
Time Duration: 
1618-1620
Publisher: 
Elsevier B.V.
Keywords: 
  • CYR61
  • prostate
  • dog
Source: 
http://dx.doi.org/10.1016/j.theriogenology.2006.01.050
URI: 
Access Rights: 
Acesso restrito
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/13643
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.